Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
2.420
+0.030 (1.26%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $20.84 million as of August 7, 2026. Its market cap has decreased by -79.96% in one year.
Market Cap
20.84M
Enterprise Value
-10.88M
1-Year Change
-79.96%
Ranking
Category
Stock Price
$2.42
ChartMarket Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has decreased from $62.00M to $20.84M, a decrease of -66.39%. That is a compound annual growth rate of -7.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 20.80M | -72.70% |
| Dec 31, 2025 | 76.20M | -35.86% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
| Nov 8, 2012 | 62.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 21.51M |
| Neuphoria Therapeutics | 21.08M |
| GridAI Technologies | 20.39M |
| NextCure | 20.19M |
| Cellectar Biosciences | 20.14M |
| Quantum BioPharma | 20.06M |
| Daré Bioscience | 19.92M |
| Cocrystal Pharma | 19.84M |